Medtronic ROCE 2024

Medtronic ROCE

0.12

Medtronic Dividend yield

3.41 %

Ticker

MDT

ISIN

IE00BTN1Y115

WKN

A14M2J

In 2024, Medtronic's return on capital employed (ROCE) was 0.12, a -6.2% increase from the 0.13 ROCE in the previous year.

Medtronic Aktienanalyse

What does Medtronic do?

Medtronic PLC is a globally leading medical technology company headquartered in Dublin, Ireland. The company was founded in 1949 by Earl Bakken and Palmer Hermundslie and has since developed a comprehensive portfolio of products in the field of medical devices and equipment. Medtronic's business model is focused on meeting the demand for innovative medical technology to improve the quality of life for patients and treat or alleviate diseases and disorders. The company strives to constantly invest in research and development to bring new and improved products to the market. Medtronic offers an extensive range of products that can be used in the fields of cardiology, neuromodulation, spinal surgery, diabetes, hearing aids, surgery, ophthalmology, infection prevention, percutaneous intervention procedures, and more. One of the most well-known product series is the pacemaker, which has been manufactured by Medtronic in a variety of models since 1957. In the field of neuromodulation, Medtronic is a leader in the development of implants that can treat various disorders of the nervous system. This includes deep brain stimulation (DBS) for Parkinson's disease, as well as spinal cord stimulation procedures for chronic pain and neurostimulation procedures for bladder, bowel, and gastrointestinal disorders.. In the field of spinal medicine, Medtronic offers a variety of devices that contribute to the stabilization of the spine and can be implemented through minimally invasive procedures. These include products such as plate systems, cages, spinal stabilizations, chamber drains, medication pumps, and more. In the field of diabetes, Medtronic focuses on the development of insulin pump systems that allow for more precise administration of insulin. The system also includes a sensor that continuously monitors blood sugar levels and can trigger insulin delivery as needed. Medtronic is also known for its efforts in infection prevention, offering products such as antimicrobial catheters, wound care, and hospital hygiene solutions. In addition to its products, the company is also involved in medical education and consulting. As part of these efforts, Medtronic develops training and education programs for physicians and healthcare personnel to enhance techniques and the use of devices and systems. Over the years, Medtronic has expanded its product offering through mergers and acquisitions. Currently, the company employs over 86,000 people in locations across more than 160 countries worldwide. Overall, Medtronic aims to drive innovation in medical technology and enable better healthcare for patients worldwide through its products and services. Medtronic ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Medtronic's Return on Capital Employed (ROCE)

Medtronic's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Medtronic's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Medtronic's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Medtronic’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Medtronic Stock

What is the ROCE (Return on Capital Employed) of Medtronic this year?

The ROCE of Medtronic is 0.12 undefined this year.

How has the ROCE (Return on Capital Employed) of Medtronic developed compared to the previous year?

The ROCE of Medtronic has increased by -6.2% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Medtronic?

A high Return on Capital Employed (ROCE) indicates that Medtronic has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Medtronic?

A low ROCE (Return on Capital Employed) can indicate that Medtronic has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Medtronic impact the company?

An increase in the ROCE of Medtronic can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Medtronic affect the company?

A decrease in ROCE of Medtronic can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Medtronic?

Some factors that can affect Medtronic's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Medtronic so important for investors?

The ROCE of Medtronic is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Medtronic take to improve the ROCE?

To improve the ROCE, Medtronic can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Medtronic pay?

Over the past 12 months, Medtronic paid a dividend of 2.75 USD . This corresponds to a dividend yield of about 3.41 %. For the coming 12 months, Medtronic is expected to pay a dividend of 2.81 USD.

What is the dividend yield of Medtronic?

The current dividend yield of Medtronic is 3.41 %.

When does Medtronic pay dividends?

Medtronic pays a quarterly dividend. This is distributed in the months of July, October, January, April.

How secure is the dividend of Medtronic?

Medtronic paid dividends every year for the past 48 years.

What is the dividend of Medtronic?

For the upcoming 12 months, dividends amounting to 2.81 USD are expected. This corresponds to a dividend yield of 3.49 %.

In which sector is Medtronic located?

Medtronic is assigned to the 'Health' sector.

Wann musste ich die Aktien von Medtronic kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Medtronic from 4/12/2024 amounting to 0.69 USD, you needed to have the stock in your portfolio before the ex-date on 3/21/2024.

When did Medtronic pay the last dividend?

The last dividend was paid out on 4/12/2024.

What was the dividend of Medtronic in the year 2023?

In the year 2023, Medtronic distributed 2.67 USD as dividends.

In which currency does Medtronic pay out the dividend?

The dividends of Medtronic are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Medtronic stock can be added to a savings plan with the following providers: Scalable Capital and Consorsbank

Andere Kennzahlen von Medtronic

Our stock analysis for Medtronic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Medtronic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.